Plunkett Research Online: Cantabio Pharmaceuticals

CANTABIO PHARMACEUTICALS (CTBO) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson’s disease and Alzheimer’s disease and other related dis.....


CANTABIO PHARMACEUTICALS

Ticker: CTBO
Exchange: OTCM
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 408 501-8893
Fax: 408 501-8808
Address:
Palo Alto, 94303

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Gergely TothCEO/President/Director
Simon PeaceChief Accounting Officer
See More
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson’s disease and Alzheimer’s disease and other related dis.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture